SG Americas Securities
TNYA icon

SG Americas Securities’s Tenaya Therapeutics TNYA Stock Holding History

SG Americas Securities’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,168
Closed -$10K – 3590
2025
Q1 		$10K Sell
17,168
-24,102
-58% -$23.8K ﹤0.01% 3410
2024
Q4 		$59K Buy
41,270
+15,777
+62% +$35.4K ﹤0.01% 2876
2024
Q3 		$49K Buy
+25,493
New +$72K ﹤0.01% 3254
2024
Q2 		– Sell
-16,194
Closed -$85K – 3308
2024
Q1 		$85K Sell
16,194
-9,143
-36% -$43.7K ﹤0.01% 2610
2023
Q4 		$82K Buy
25,337
+4,224
+20% +$9.12K ﹤0.01% 2820
2023
Q3 		$54K Buy
+21,113
New +$88.4K ﹤0.01% 2922
2023
Q2 		– Sell
-15,442
Closed -$44K – 3154
2023
Q1 		$44K Buy
+15,442
New +$43.4K ﹤0.01% 3080
2022
Q4 		– Sell
-10,476
Closed -$30K – 3378
2022
Q3 		$30K Sell
10,476
-62
-0.6% -$289 ﹤0.01% 3062
2022
Q2 		$59K Buy
+10,538
New +$85.3K ﹤0.01% 3244
2021
Q4 		– Sell
-6,237
Closed -$129K – 3806
2021
Q3 		$129K Buy
+6,237
New +$134K ﹤0.01% 3536

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SG Americas Securities's TNYA Position: Q2 2025 in Review

SG Americas Securities sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 17,168 shares — an estimated $10K sold.

SG Americas Securities first reported a position in TNYA in Q3 2021 and held it in 10 quarters. The position peaked at $129K in Q3 2021. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • SG Americas Securities reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 17,168 Tenaya Therapeutics shares in Q2 2025, an estimated $10K.
  • SG Americas Securities first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 10 quarters.
  • SG Americas Securities's Tenaya Therapeutics position peaked at $129K in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.